| Literature DB >> 30241100 |
Richard Dodel1, Jiri Koschel2, Stefan Lorenzl3, Johannes Levin4, Thilo van Eimeren5, Günter Höglinger6.
Abstract
Dementia with Lewy bodies is characterized histopathologically by the deposition of α-synuclein in inclusion bodies. Clinical diagnosis is based on progressive cognitive deficits, cognitive fluctuations, early visual hallucinations, REM sleep disorders and symptoms of Parkinsonism. On the basis of the new criteria published in 2017, better differentiation from other neurodegenerative diseases with dementia should be possible. Therapy concepts include treatment of loss of motor and cognitive performance as well as psychological and behavioral symptoms. At present, only a few studies are available on this clinical picture so that evidence-based therapy approaches are only possible to a limited extent. © Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Year: 2018 PMID: 30241100 DOI: 10.1055/a-0696-6249
Source DB: PubMed Journal: Fortschr Neurol Psychiatr ISSN: 0720-4299 Impact factor: 0.752